CureVac N.V’s recent filing unveils that its affiliate Myriam Mendila acquired Company’s shares for reported $88019.0 on Jan 07 ’25. In the deal valued at $4.93 per share,17,839 shares were bought.
Then, Pierre Kemula bought 51,523 shares, generating $254,219 in total proceeds.
Before that, Alexander Zehnder bought 26,104 shares. CureVac N.V shares valued at $128,800 were divested by the affiliate at a price of $4.93 per share.
Leerink Partners downgraded its CureVac N.V [CVAC] rating to a Market perform from a an Outperform in a research note published on April 25, 2024; the price target was decreased to $4 from $12. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in early June with a ‘”an Outperform”‘ rating. UBS also remained covering CVAC and has increased its forecast on January 19, 2023 with a “Buy” recommendation from previously “Neutral” rating. Jefferies revised its rating on January 09, 2023. It rated CVAC as “a Buy” which previously was an “a Hold”.
Price Performance Review of CVAC
On Tuesday, CureVac N.V [NASDAQ:CVAC] saw its stock jump 5.41% to $4.68. Over the last five days, the stock has gained 50.00%. CureVac N.V shares have risen nearly 37.24% since the year began. Nevertheless, the stocks have risen 7.83% over the past one year. While a 52-week high of $5.28 was reached on 01/07/25, a 52-week low of $2.21 was recorded on 01/02/25. SMA at 50 days reached $2.98, while 200 days put it at $3.16.
Levels Of Support And Resistance For CVAC Stock
The 24-hour chart illustrates a support level at 4.42, which if violated will result in even more drops to 4.17. On the upside, there is a resistance level at 4.97. A further resistance level may holdings at 5.26. The Relative Strength Index (RSI) on the 14-day chart is 82.48, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.93, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 13.79%. Stochastics %K at 91.54% indicates the stock is a selling.
How much short interest is there in CureVac N.V?
A steep rise in short interest was recorded in CureVac N.V stocks on 2024-12-13, dropping by -0.47 million shares to a total of 3.94 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 4.41 million shares. There was a decline of -12.0%, which implies that there is a negative sentiment for the stock.
